You are here

ARTIFICIAL CELL TECHNOLOGIES INC

Company Information
Address
5 SCIENCE PARK STE 13
NEW HAVEN, CT 06511-1989
United States


http://www.artificialcelltech.com

Information

UEI: FA75DFVZ55D1

# of Employees: 9


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Formulation of LbL microparticle vaccine in microneedle array for intradermal del

    Amount: $110,923.00

    Abstract The ability of the immune system to recognize and initiate an immune response to foreign particles such as bacteria and viruses has generated interest in development of particulate vaccine te ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  2. Synthetic microparticle malaria vaccine

    Amount: $2,700,895.00

    DESCRIPTION provided by applicant This Phase II project will develop a novel synthetic microparticle vaccine for malaria using the T BT epitopes of the circumsporozoite CS protein of Plasmodium ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  3. Synthetic nanoparticle vaccines for RSV

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the most important cause of severe lower respiratory tract illness in infants and the elderly. There is no approved vaccine de ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  4. Synthetic nanocapsule malaria vaccines

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The goal of this project is to produce novel synthetic malaria vaccines based on epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causa ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  5. Polypeptide Multilayer Nanofilms for Synthetic Biomatrix Development

    Amount: $331,582.00

    DESCRIPTION (provided by applicant): This SBIR Phase I project will determine the feasibility of applying polypeptide multilayer nanofilm technology to synthetic biomatrix development and commercializ ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government